0001209191-20-065033.txt : 20201223 0001209191-20-065033.hdr.sgml : 20201223 20201223170026 ACCESSION NUMBER: 0001209191-20-065033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schuetz Thomas J. CENTRAL INDEX KEY: 0001591464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39696 FILM NUMBER: 201413301 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Compass Therapeutics, Inc. CENTRAL INDEX KEY: 0001738021 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-500-8099 MAIL ADDRESS: STREET 1: 245 FIRST STREET, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Olivia Ventures, Inc. DATE OF NAME CHANGE: 20180419 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-22 0 0001738021 Compass Therapeutics, Inc. CMPX 0001591464 Schuetz Thomas J. C/O COMPASS THERAPEUTICS 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 5.00 2020-12-22 4 A 0 250000 0.00 A 2030-12-22 Common Stock 250000 250000 D 50% of this option is immediately vested and exercisable, with the remainder vesting in 24 substantially equal monthly installments thereafter. /s/ Thomas J. Schuetz 2020-12-23